{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:27:27Z","timestamp":1787682447718,"version":"build-2784847793"},"reference-count":2,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T00:00:00Z","timestamp":1646697600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vox Sanguinis"],"published-print":{"date-parts":[[2022,6]]},"abstract":"Abstract<\/jats:title>Background and Objectives<\/jats:title>Actions are needed to improve access to safe plasma\u2010derived medicinal products (PDMPs) in low\u2010 and middle\u2010income countries (LMICs).<\/jats:p><\/jats:sec>Materials and Methods<\/jats:title>The International Society of Blood Transfusion (ISBT) Working Party for Global Blood Safety organized an on\u2010line workshop during 21\u201323 September 2021 to advance access to safe plasma proteins in resource\u2010constrained countries, consistent with recent World Health Organization (WHO) guidance documents.<\/jats:p><\/jats:sec>Results<\/jats:title>The meeting drew attention to the considerable unmet needs for access to essential PDMPs in LMICs, in particular coagulation factors and immunoglobulins, and stepwise actions to address these deficits. First, improved access to safe plasma protein therapies requires blood component separation with prevention of wastage of recovered plasma. Quality and safety of collected blood and plasma must be assured so that plasma in excess of transfusion needs can be processed into safe plasma proteins. Second, local production of safe plasma proteins can be implemented using available technologies to locally obtain pathogen\u2010reduced plasma and prepare pathogen\u2010reduced cryoprecipitate and immunoglobulins from small plasma pools. Third, when a sufficient, stable volume of quality\u2010assured plasma is available (approximately 50,000\u2009L\/year), contract or toll fractionation by a foreign plasma fractionator can expand the supply of PDMPs. Fourth, when the national infrastructure supports high\u2010technology industrial production and stable volumes of quality plasma reach at least 200,000\u2009L\/year, technology transfer for domestic fractionation can be considered.<\/jats:p><\/jats:sec>Conclusion<\/jats:title>Action is needed including commitments of the organizations that made the workshop possible (WHO, ISBT, World Federation of Haemophilia [WFH], Plasma Protein Therapeutics Association [PPTA], International Plasma Fractionation Association [IPFA], International Patient Organization of Primary Immunodeficiencies [IPOPI] and International Federation of Blood Donor Organizations [FIODS]).<\/jats:p><\/jats:sec>","DOI":"10.1111\/vox.13263","type":"journal-article","created":{"date-parts":[[2022,3,8]],"date-time":"2022-03-08T16:56:16Z","timestamp":1646758576000},"page":"789-795","source":"Crossref","is-referenced-by-count":15,"title":["Stepwise access to safe plasma proteins in resource\u2010constrained countries: Local production and pathways to fractionation\u2014Report of an International Society of Blood Transfusion Workshop"],"prefix":"10.1111","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0507-9243","authenticated-orcid":false,"given":"Thierry","family":"Burnouf","sequence":"first","affiliation":[{"name":"Graduate Institute of Biomedical Materials and Tissue Engineering College of Biomedical Engineering, Taipei Medical University Taipei Taiwan"},{"name":"International PhD Program in Biomedical Engineering College of Biomedical Engineering, Taipei Medical University Taipei Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2293-9062","authenticated-orcid":false,"given":"Jay","family":"Epstein","sequence":"additional","affiliation":[{"name":"McLean Virginia USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean\u2010Claude","family":"Faber","sequence":"additional","affiliation":[{"name":"Association Luxembourgeoise des H\u00e9mophiles Luxembourg City Luxembourg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8487-0043","authenticated-orcid":false,"given":"Martin","family":"Smid","sequence":"additional","affiliation":[{"name":"Sanquin Consulting Services Academic Institute IDTM Amsterdam & Groningen The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,3,8]]},"reference":[{"key":"e_1_2_10_2_1","unstructured":"WHO Guidance on increasing supplies of plasma\u2010derived medicinal products in low\u2010 and middle\u2010income countries through fractionation of domestic plasma [cited 2021 Dec 24]. Available from:https:\/\/apps.who.int\/iris\/handle\/10665\/340171"},{"key":"e_1_2_10_3_1","unstructured":"WHO Guidance on centralization of blood donation testing and processing [cited 2021 Dec 24]. Available from:https:\/\/www.who.int\/publications-detail-redirect\/9789240020825"}],"container-title":["Vox Sanguinis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/vox.13263","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/vox.13263","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/vox.13263","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T09:37:20Z","timestamp":1692869840000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/vox.13263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,8]]},"references-count":2,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["10.1111\/vox.13263"],"URL":"https:\/\/doi.org\/10.1111\/vox.13263","archive":["Portico"],"relation":{},"ISSN":["0042-9007","1423-0410"],"issn-type":[{"value":"0042-9007","type":"print"},{"value":"1423-0410","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,8]]}}}